[Cancers and multiple sclerosis: risk of comorbidity and influence of disease modifying therapy].
Data of clinical-epidemiological studies on the risk of cancer in patients with multiple sclerosis (MS) are discussed. A trend towards increased risks of brain tumors and urological cancers has been shown. The author considers risk factors, including disease modifying therapies (DMT), for different cancers. It has been concluded that longitudinal observational and large cohort studies along with MS registers are needed to clarify a role of DMD in the development of malignant neoplasms.